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Chlamydia trachomatis serovar E, the leading bacterial agent responsible for sexually transmitted diseases,
is required to invade genital epithelial cells for its growth and survival, yet little is known about the adhesin-
receptor interactions promoting its entry. In contrast, much has been published on the heparan sulfate
receptor for binding C. trachomatis L2 elementary bodies (EBs) prior to entry into HeLa cells. Using a different
experimental approach in which a biotinylated apical membrane protein receptor(s) attached to EB at 4°C was
stripped off the surface of polarized HEC-1B cells and immunoprecipitated with polyclonal anti-EB antibodies,
an 55-kDa protein was reproducibly detected by enhanced chemiluminescence and two-dimensional gel
electrophoresis. Matrix-assisted laser desorption ionization mass–spectrometry sequence analysis revealed the
55-kDa protein to be protein disulfide isomerase (PDI), a member of the estrogen receptor complex which
carries out thiol-disulfide exchange reactions at infected host cell surfaces. Exposure of HEC-1B cells during
EB attachment (1.5 to 2 h) to three different inhibitors of PDI reductive reactions—(i) the thiol-alkylating
reagent DTNB (5,5-dithiobis[2-nitrobenzoic acid]), (ii) bacitracin, and (iii) anti-PDI antibodies—resulted in
reduced chlamydial infectivity. Since (i) C. trachomatis serovar E attachment to estrogen-dominant primary
human endometrial epithelial cells is dramatically enhanced and (ii) productive entry into and infectivity of EB
in host cells is dependent on reduction of EB cross-linked outer membrane proteins at the host cell surface,
these data provide some preliminary evidence for an intriguing new potential receptor candidate for further
analysis of luminal C. trachomatis serovar E entry.
Chlamydia trachomatis serovars D to K are the predominant
cause of bacterial sexually transmitted diseases and sequelae in
the United States and worldwide (25). These bacteria are
thought to be luminal pathogens, entering and exiting the
apical surfaces of target columnar epithelial cells lining the
genital mucosae. They ascend canalicularly in the female gen-
ital tract from the endocervix to the endometrium and, subse-
quently, to the fallopian tubes. In contrast, the Lymphogran-
uloma venereum (LGV) serovars L1 to L3 of C. trachomatis
are disseminating pathogens, exiting the basal surfaces of ep-
ithelial cells lining the endocervix or the urethra. The chlamyd-
iae then spread through the submucosa to regional lymph
nodes; an inguinal lymphadenopathy is a common clinical
manifestation of this sexually transmitted disease syndrome
(25).
Since these bacteria are obligate intracellular pathogens,
they must initially attach to and enter the apical surfaces of
epithelial host cells. While a few chlamydial envelope compo-
nents have been proposed as adhesins (2, 6, 12, 19, 21, 27, 29,
32) and even fewer epithelial plasma membrane components
have been proposed as receptors (14, 31, 33, 36), the leading
candidate adhesin-receptor combination seems to be heparan
sulfate, at least in in vitro studies. In a series of studies by
Stephens and colleagues (reviewed in reference 27), a chla-
mydia biosynthetically directed heparan sulfate was proposed
as the adhesin for the LGV L2 serovar (18). These data have
recently been confirmed, although there may still be some
controversy as to the origin of the heparan sulfate, i.e., is it
prokaryote or eukaryote derived (33)? While the chlamydial
genomes have no open reading frames encoding genes for
heparan sulfate, it has been suggested that some of the chla-
mydial open reading frames coding for the enzymatic machin-
ery may yet be unassigned, or alternatively, the chlamydiae
may exploit substrate intermediates supplied by the host (18).
Su et al. (31) suggested that heparan sulfate also serves as the
receptor for the C. trachomatis mouse pneumonitis serovar by
expressing in Escherichia coli a recombinant maltose binding
protein-major outer membrane protein (MBP-MOMP) fusion
protein which, in turn, binds specifically to heparan sulfate
receptors on HeLa cells. However, this same group also found
that heparan sulfate had no competitive inhibitory effect on
establishment of chlamydial genital infection in mice (30). Per-
haps the extended molecules of the high-mannose oligoman-
nose oligosaccharide glycosylated to MOMP (12) serve as an
initial adhesin to bring the infectious form of chlamydia—the
elementary body (EB)—closer to the epithelial cell for
MOMP-heparan sulfate interaction, leading to entry, or alter-
natively, they use separately mannose-binding receptors.
Little information is available on the receptor for the non-
disseminating, non-LGV serovars of C. trachomatis (14). The
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EB of these D to K serovars are less susceptible to interference
of attachment to HeLa cells by heparan sulfate (4, 33). Fur-
ther, Hayashi et al. (9) demonstrated by immunocytochemistry
at both the light- and electron-microscopic levels that heparan
sulfate was localized only to the basal surfaces of genital co-
lumnar epithelial cells of mouse tissues in vivo. Such basal
laminal or interstitial matrix proteins may be redistributed
differently, i.e., circumferentially, in nonpolarized epithelial
cells cultured in vitro (37). Our laboratory previously examined
the endometrial epithelial cell line HEC-1B, grown on cover-
slips, for the presence of integrins (39). These endometrial
cells were moderately to strongly positive for 13 out of 24
major integrins, mostly , v, and . Monoclonal antibodies
recognizing seven of these integrins were added to HEC-1B
cells, but this maneuver had no effect on blocking serovar E EB
attachment, whereas there was markedly decreased attach-
ment of the positive control Yersinia pseudotuberculosis, which
binds RGD sequences. Recent chlamydial genomic analyses of
the multigene family encoding polymorphic outer membrane
proteins (POMPs) suggest the POMPs may have autotrans-
porter function (10). Indeed, the passenger domain of POMPs
from several Chlamydia species, including C. trachomatis, con-
tains RDG motifs. While the authors point out that RGD
motifs are often associated with proteins predicted to be ad-
hesins, these functional motifs are common and also are seen
in proteins that do not require cell adhesion properties.
This study presents a different approach designed to identify
receptor components on HEC-1B cells involved in attachment
of C. trachomatis serovar E EB. The key strategy was to isolate
and identify by matrix-assisted laser desorption ionization–
mass spectrometry (MALDI-MS) chemiluminescence-labeled
apical membrane proteins associated with EB during attach-
ment, subsequently immunoprecipitated with EB, and resolved
by isoelectric focusing. Our report focuses on one member of
the estrogen receptor complex (13) which carries out thiol-
disulfide exchange reactions at cell surfaces—a prerequisite for
EB infection.
MATERIALS AND METHODS
Chlamydia and host cell lines. C. trachomatis serovar E (UW5-CX) was
cultured in McCoy cells grown on Cytodex microcarrier beads (26) (Pharmacia,
Uppsala, Sweden), purified by Percoll (Sigma) gradient centrifugation for EB
particle count determination, and stored in 2SPG (0.02 M phosphate buffer, 0.2
M sucrose, 5 mM glutamine [pH 7.2]) at 80°C (4). The titers of aliquots of
frozen and thawed stock samples of EB were determined by fluorescent-inclu-
sion count in McCoy cell monolayers, fixed with methanol, stained with a pool of
fluorescein-labeled monoclonal antibodies generated against C. trachomatis
MOMP (Syva [now Wampole, Carter-Wallace, Inc.], Palatine, Ill.), suspended in
Evans blue counterstain, and examined on a Zeiss Axiovert 10 microscope
equipped with 495-nm excitation and 520-nm emission filters.
The human endometrial carcinoma subclone 1B (HEC-1B; ATCC HTB-113)
epithelial cell line, cultured in Dulbecco’s modified Eagle medium (D-MEM;
Gibco, Grand Island, N.Y.) with 10% fetal calf serum (FCS) (D-MEM-10) and
2 mM glutamine, was used for apical membrane protein isolation.
Apical membrane protein isolation and identification. HEC-1B cells were
seeded (105 cells/filter) onto each filter of six-well filter inserts (ca 4.7 cm2; Costar
Transwell), incubated at 37°C until the confluent monolayer became polarized,
and monitored microscopically via a control monolayer on a clear (Costar
Transcol) filter insert. A minimum of 12 inserts was used per experimental
sample. Two days prior to labeling apical membranes, the concentration of FCS
was reduced to 3%.
(i) Labeling of apical membrane proteins. Labeling of HEC-1B apical mem-
brane proteins was performed by biotinylation (ECL kit; Amersham) using the
reagents, unless otherwise specified, and protocol provided by the manufacturer.
Briefly, HEC-1B polarized monolayers, washed twice in phosphate-buffered sa-
line (PBS) containing protease inhibitors (Protease Inhibitor Cocktail, Boehr-
inger Mannheim), were exposed to the biotinylation reagent (diethyl formamide-
biotinamide-N-OH succinamide ester) in bicarbonate buffer (pH 8.6; 200 l per
filter insert) and placed on a rocking platform for 30 min at 4°C. Subsequently,
the biotinylated monolayers were washed two times in PBS containing Ca2 (0.7
mM) and Mg2 (0.5 mM).
(ii) Attachment of EB. Percoll-purified C. trachomatis serovar E EB stock in
2SPG was diluted in Hanks balanced salt solution, pH 7.2, to a multiplicity of
infection of 200:1 and inoculated onto the biotinylated HEC-1B monolayers (150
l/filter); the six-well plates were placed on a rocking platform at 4°C for 1 h to
allow EB attachment. Unattached EBs were then removed by washing the mono-
layers two times in PBS, pH 7.5.
(iii) Apical membrane lift. Isolation of apical membranes, with or without EB
attached, was accomplished by pressing a poly-L-lysine-coated coverslip, gently
but firmly, onto the surface of the polarized monolayer and then lifting off the
coverslip (24, 38). Two control coverslips were fixed with cold methanol, stained
with a pool of fluorescein-labeled monoclonal antibodies generated against C.
trachomatis MOMP (Syva) suspended in Evans blue counterstain, and examined
microscopically to monitor for efficient EB attachment as well as the absence of
whole (contaminating) HEC-1B cells. A minimum of 10 to 12 coverslips con-
taining attached and/or transferred apical membrane were subjected to 0.1%
NP-40 (200 l per coverslip) for 30 min at 4°C to solubilize apical membrane
proteins; importantly, this step does not affect EB infectivity. Following two
additional washes in lysis buffer and scraping the coverslips with a rubber po-
liceman, the washes were combined, briefly centrifuged to remove large debris,
concentrated (from 3.0 to 0.5 ml) in an Amicon concentrator (5,000 rpm for 45
min in a Sorvall SS-34 rotor), and assayed for protein concentration by the BCA
microassay (Pierce Chemical Co.).
(iv) Immunoprecipitation. More reproducible results were obtained if a pre-
clearing step was added prior to immunoprecipitation of lysate supernatants
containing EB with an attached, biotinylated apical membrane protein(s). This
consisted of adding 30 l of protein A (Ultralink; Pierce) per 40 g of lysate
protein and incubating for 1 to 2 h at 4°C. The protein A-Sepharose bead slurry
was then removed by centrifugation at 13,000 rpm for 1 min (Sorvall MC-12
rotor).
Lysate supernatants were transferred to fresh tubes containing either whole
(1 g of protein/l) or immunoglobulin G (IgG)-purified (5 g of protein/l)
anti-EB (rabbit) antiserum (prepared in our laboratory via repeated intravenous
injections of live EB over 6 months) or normal, nonimmune rabbit serum (1 g
of protein/l) and rocked on a platform for 2 to 3 h at 4°C. Protein A-conjugated
beads (40 l) were added to the samples for an additional 2-h incubation. The
immunoprecipitated chlamydial EB-protein A beads were sedimented at 2,500 
g for 3 min at 4°C, and the pellets were washed six times in lysis buffer for 5 min
at 4°C, washed once in deionized distilled water, and finally subjected to one- and
two-dimensional electrophoresis, as previously described (20).
(v) Chemiluminescence. Resolved proteins were detected by chemilumines-
cence. Samples were transferred to nitrocellulose membrane (75 mA overnight;
Hybond ECL membrane; Amersham International, Little Chalfont, Bucking-
hamshire, England), blocked with 3% gelatin, exposed for 1 h to neutravidin-
conjugated horseradish peroxidase (1:10,000; Pierce), washed five times, exposed
to the enhanced chemiluminescence (ECL) detection reagents, and processed 1
to 4 min on blue-light-sensitive autoradiography film (Hyperfilm; Amersham).
All experiments were performed a minimum of six times on separate occasions.
(vi) MALDI-MS. Isoelectric focusing (20) of unlabeled apical membrane pro-
teins was performed in preparation for peptide mass mapping. Unlabeled apical
membrane proteins, located via Gel Code Blue staining (Pierce), were excised
from three to four two-dimensional gels and mailed to the Protein Core Facility,
Howard Hughes Medical Institute, Columbia University, New York, N.Y., for
in-gel digestion with endoproteinase Lys-C and MALDI-MS.
Measurement of sulfhydryl blocking reactions. HEC-1B cells, in D-MEM-10,
were grown to subconfluency in four-well plates (Nalge Nunc International,
Naperville, Ill.). After washing with PBS, the epithelial host cells were exposed
for 30 min at 4 or 35°C to one of the following: (i) the membrane-impermeable,
thiol-alkylating reagent DTNB (1 mM; 5,5-dithiobis[2-nitrobenzoic acid]); (ii)
bacitracin (3 mM; Sigma); (iii) an anti-protein disulfide isomerase (anti-PDI)
monoclonal antibody (IgG2a; MA3-019, clone RL-90; Affinity Reagents,
Golden, Colo.); (iv) an irrelevant mouse IgG control antibody; or (v) D-MEM
without FCS. Then, C. trachomatis serovar E EBs, diluted to provide a 50%
infection per cell monolayer, were added to each HEC-1B monolayer and incu-
bation was continued for 1.5 to 2 h at 4 or 35°C. The monolayers were then
washed, replenished with fresh medium, and incubated for 48 h at 35°C. Qua-
druplicate coverslips were fixed with cold methanol, stained with the fluorescein-
3414 DAVIS ET AL. INFECT. IMMUN.
labeled monoclonal antibodies directed against C. trachomatis MOMP (Syva),
and examined by fluorescence microscopy for chlamydial infectivity or neutral-
ization thereof by inclusion counting. The fluorescent chlamydial inclusions in 30
grid fields at a magnification of 40 were counted. All measures of statistical
significance were determined using a two-tailed Student’s t test. Each experiment
was performed a minimum of three times on separate days.
Assembly of data. Gels and the Western blot were scanned using a Microtek
ScanMaker III and assembled using Adobe Photoshop 5.0 and Adobe Page-
maker 6.0 software for the Power Macintosh.
RESULTS AND DISCUSSION
Endometrial epithelial apical membrane proteins associ-
ated with attached EB. Biotinylated apical membrane proteins,
with or without attached C. trachomatis serovar EB (Fig. 1),
were analyzed by sodium dodecyl sulfate–12.5% polyacryl-
amide gel electrophoresis (SDS–12.5% PAGE) and detected
with neutravidin-horseradish peroxidase and chemilumines-
cence. A unique protein of 55 kDa was reproducibly associ-
ated with immunoprecipitated EB using immune rabbit serum
(Fig. 1A); proteins of 90 and 45 kDa were also frequently
detected (data not shown).
Isoelectric focusing of both biotinylated and unlabeled api-
cal membrane proteins, with or without attached and immu-
noprecipitated EBs, was performed. Control unlabeled apical
membrane proteins without associated EBs provided an apical
membrane protein profile. Both Gel Code Blue staining of
unlabeled proteins and chemiluminescent staining of labeled
FIG. 1. Electrophoretic analysis of endometrial epithelial apical membrane proteins associated with attached, infectious EB. (A) A 40-g
amount of total protein per lane from biotinylated apical membrane lysates immunoprecipitated with C. trachomatis serovar E EB was resolved
by SDS-PAGE (12.5% gel) and visualized by ECL, as described in Materials and Methods. Samples included the following: EB immunoprecipi-
tated with immune rabbit serum (IRS) (2 l), EB immunoprecipitated with IRS (1 l), EB immunoprecipitated with normal rabbit serum (NRS)
(1 l), no EB plus IRS (1 l), and no EB plus NRS (1 l). The star denotes a unique 55-kDa biotinylated apical membrane protein reproducibly
associated with immunoprecipitated EB (second and third lanes). (B to D) A 40-g amount of total protein from apical membrane lysates
immunoprecipitated with EB was focused in a pH range from 3 to 10 in the first dimension and separated by SDS-PAGE in the second dimension.
Gels were subjected to ECL (B and C) and Western blotting (D). (C) A photographic enlargement of some of the proteins in the acidic range is
illustrated. Duplicate unlabeled proteins identified by MALDI-MS were as follows: spot 1, hsp60; spot 2, PDI; spot 3, unidentified (amount too
small); spot 4, 78-kDa glucose regulatory protein; spot 5,  actin; spot 6, ATP synthase. Spot 2, identified as PDI, shows immunoreactivity with
anti-PDI monoclonal antibody (100 g/ml; 1/100 dilution) upon Western blotting (D). (A, B, and D) M, molecular mass markers.
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proteins revealed a number of acidic proteins in the 46- to
68-kDa range (Fig. 1B). Six proteins with theoretical pIs rang-
ing between 4.69 and 5.29 (Fig. 1C) were analyzed by MALDI-
MS. The 55-kDa apical membrane protein repeatedly asso-
ciated with immunoprecipitated EB (spot 2) was identified as
PDI (Swiss-Prot accession no. P07237; p55) (Table 1), a com-
ponent of the hormone receptor complexes thyrotropin (3) and
estrogen (13). Other proteins were reported as follows: spot 1,
heat shock protein 60 (hsp60); spot 3, unidentified (amount
too small); spot 4, 78-kDa glucose regulatory protein in the
hsp70 family; spot 5,  actin; and spot 6, ATP synthase. Con-
firmation that the 55-kDa protein (spot 2) is PDI was ob-
tained by Western blot detection with anti-PDI antibody (Fig.
1D).
Thiol-disulfide exchange reactions at the infected eukaryotic
cell surface. While most PDI is located in the endoplasmic
reticulum (17), some is clearly recycled to the eukaryotic cell
surface, where it is known to carry out thiol-disulfide inter-
change reactions (5, 11). One example of exploitation of sur-
face PDI-catalyzed disulfide reactions is chain separation of
diphtheria toxin, which results in host cell cytotoxicity (15, 22).
Similar reactions in the highly disulfide-cross-linked EB enve-
lope are crucial for triggering the transition of EB to reticulate
bodies and, perhaps, even earlier conformational rearrange-
ments within kinetically trapped, folded structural proteins for
attachment and entry (7, 8, 21). Since thiol exchange reactions
occur at a very rapid rate, i.e., once every 106 s at 35°C, we
used three approaches for examining sulfhydryl blocking and
the role of PDI during chlamydial attachment and used chla-
mydial infectivity as a readout. It should be noted that infec-
tious serovar E EBs attach to host apical surfaces in essentially
equal numbers at 35 and 4°C.
The importance of cross-linking and reduction during the
initial stages of EB infection of host epithelial cells was first
examined using the non-membrane-permeating, thiol-alkylat-
ing reagent DTNB (21). Exposure of chlamydiae to DTNB
during the 1- to 2-h attachment phase reduced chlamydial
infectivity 30% at 4°C and 10% at 35°C (Fig. 2). These results
are virtually identical to those obtained by Abell and Brown
(1), who showed that DTNB reduced but did not abolish Sind-
bis virus entry and infectivity of BHK-1 cells via interfering
with viral capsomere protein disulfide cross-linking. Both EB
and Sindbis virus are unique in the extent of disulfide proteins
in their respective envelopes, which have been described as
rigid external matrices with associated lipids as opposed to
fluid lipid bilayers with associated proteins (21).
Further emphasis of the importance of disulfide cleavage at
infected cell surfaces was obtained by Ryser et al. (23), who
demonstrated that, in addition to DTNB, bacitracin, a non-
membrane-permeating inhibitor of PDI activity at eukaryotic
cell surfaces, as well as anti-PDI antibody, effectively reduced
attachment of human immunodeficiency virus, via gp120 pro-
tein, and infectivity to human lymphoid cells. In a similar
fashion, the presence of bacitracin during EB attachment to
HEC-1B cells decreased chlamydial infectivity 27 to 36% at
35°C and 16 to 22% at 4°C (Fig. 3), based on comparison of the
number of inclusions in control infected but bacitracin-unex-
posed monolayers. Addition of anti-PDI monoclonal antibod-
ies to HEC-1B cells during initial chlamydial attachment re-
sulted in a marked reduction (62 to 69%) of chlamydial
infectivity at 4°C versus a modest reduction in infectivity at
35°C (Fig. 3). The fact that only partial inhibition of infectivity
was observed at 35°C is, again, likely due to the rapid rate of
disulfide-exchange reactions that occur within and between
closely located cysteine-containing polypeptides.
Protein disulfide isomerase, 55 kDa, has recently been
shown to act in concert with hsp70 as well as accessory proteins
of 45 to 48 and 90 kDa to activate the estrogen receptor—but
not the progesterone receptor—thereby enhancing the affinity
of estrogen binding and then stabilizing the complex for sub-
sequent estrogen-response element-DNA binding (13, 35). In-
terestingly, two protein disulfide isomerase-encoding genes are
identified in the C. trachomatis serovar D genome (28) (CT780
and CT783, contigs 10.1 and 10.2, respectively [http://chlamyd-
ia-www.berkeley.edu:4231/], and coordinates 915488 to 915979
and 919539 to 920585 [http://www.stdgen.lanl.gov]). Despite
presumed similarity in function, they have little sequence ho-
mology to the eukaryotic PDIs (prototype p58, Swiss-Prot ac-
cession no. P3010; LALIGN [http://workbench.sdsc.edu]). In a
FIG. 2. The thiol-alkylating reagent DTNB reduces C. trachomatis
serovar E EB infectivity in HEC-1B cells. Exposure of HEC-1B cells to
DTNB (1 mM) 30 min prior to and during attachment (1 to 2 h) of EB
reduced chlamydial inclusion counts by 30% at 35°C and 10% at 4°C,
compared to the number of inclusions formed in control, non-DTNB-
exposed infected cells. Data from two of the three experiments con-
ducted on separate occasions are represented, one in open-bar format
and the other in solid-bar format.
TABLE 1. MS analysis identified isoelectric-focusing
acidic spot 2 as PDIa






a pI 	 4.69; average mass 	 55,294.02 (Da).
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10-domain alignment comparison, sequence identity averaged
23.8%, and the chlamydial PDIs clearly lack key eukaryotic
PDI domains, such as the endoplasmic reticulum retention and
nuclear localization signals. Further, the chlamydial PDIs pos-
ses only one thioredoxin domain versus two thioredoxin do-
mains in eukaryotic PDIs, and again, there is little sequence
homology between the prokaryotic and eukaryotic amino-ter-
minal thioredoxin domains (Prosite accession no. for thio-
redoxin, PS00194; ●. Ndjinn, http://workbench.sdsc.edu). The
chlamydial outer membrane proteins, MOMP (OmpA), and
the 60-kDa protein (OmcB) are cysteine rich, are highly disul-
fide cross-linked and have been shown to possess adhesin func-
tion (7, 8, 32, 34). One might speculate that the eukaryotic
55-kDa PDI, during EB association at the endometrial epi-
thelial apical membrane, serves as “the universal trigger for
reduction of the supramolecular cross-linked EB outer mem-
brane complex” (8), thereby exposing OmpA or OmcB adhesin
domains and/or, alternatively, activating the chlamydial PDIs,
if periplasmic, for further reduction of inter- and intramolec-
ular disulfide cross-links for high-affinity, secondary adhesin
binding promoting entry.
In summary, since studies in our laboratory have shown that
(i) C. trachomatis serovar E EB attachment and infectivity are
dramatically enhanced in estrogen-dominant primary human
endometrial epithelial cells (16, 38), (ii) productive entry into
and infectivity of EB in host cells is dependent on reduction of
EB disulfide-cross-linked outer membrane proteins at the host
cell surface (21), (iii) host cell PDI is closely associated with
adherent EB, and (iv) PDI interacts with host cell estrogen
receptors (13), separate pieces of data seem to be coming
together to provide preliminary evidence for a potentially new,
interesting receptor for luminal C. trachomatis serovar E. Stud-
ies are in progress to verify these findings in estrogen- versus
progesterone-dominant primary genital epithelial cells.
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